SEC 13F Intelligence

Wilshire Advisors LLC / FATE

Wilshire Advisors LLC’s Fate Therapeutics Inc Position

Does Wilshire Advisors LLC own Fate Therapeutics Inc (FATE)? Not currently — the last reported position was 8.49M shares worth $11M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$11M
Q3 2025
Shares
8.49M
% of Portfolio
+27.71%
Quarters Held
11
position exited

Position History FATE

Reported value by quarter
Q3 ’21: $242,000Q3 ’21Q4 ’21: $239,000Q1 ’22: $158,000Q1 ’22Q2 ’22: $101,000Q4 ’23: $15,270Q4 ’23Q1 ’24: $29,969Q2 ’24: $13,392Q2 ’24Q3 ’24: $15,000Q4 ’24: $7,000Q4 ’24Q1 ’25: $13,172Q3 ’25: $11MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20258.49M$11M+27.71%
Q1 20254.1K$13,172+0.04%
Q4 20244.1K$7,0000.00%
Q3 20244.1K$15,000+0.01%
Q2 20244.1K$13,392+0.01%
Q1 20244.1K$29,969+0.01%
Q4 20234.1K$15,270+0.01%
Q2 20224.1K$101,000+0.05%
Q1 20224.1K$158,000+0.07%
Q4 20214.1K$239,000+0.09%
Q3 20214.1K$242,000+0.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Wilshire Advisors LLC’s full portfolio or all institutional holders of FATE.